EPO grants patent to OncoGenex OGX-427 for prostate cancer treatment - 研发专利新闻

添加时间:2011-04-23 原文发表:2011-04-15 人气:2

OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI), today announced that the European Patent Office (EPO) has granted European Patent Number EP1545561 entitled Oligonucleotides for Treatment of Prostate and other Cancers. The patent,...

查看所有的文章内容需要 VIP会员权限查看

点这里复制本页地址发送给您QQ/MSN上的好友

• Echo awarded method patent for Symphony

• USPTO issues new patent to Onset Medical

• Watson confirms patent challenge by Alco

• EPO Board of Appeal rejects B.Braun pate

• USPTO issues notice of allowance to Mirn

• Shire files lawsuit against Watson over

• Cubist enters license agreement with Tev

• Medical industry veteran set to play key

• USPTO issues patent to Asterand's BioMAP

• USPTO grants composition-of-matter paten

• QRxPharma receives new U.S. Patent for M

• U.S. District Court grants preliminary i

• Acorda receives patent for AMPYRA tablet

• Salix Pharmaceuticals receives three U.S

• Watson Laboratories seeks FDA approval t

• WSU researcher develops potential vaccin

• USPTO issues patent to Oragenics ProBior

• POZEN, AstraZeneca file lawsuit against

• Pro-Pharmaceuticals receives method pate

• NovaSterilis novel vaccine patent

网站首页

行业信息

市场快讯

SFDA新闻精选

调研报告

研发动态

研发专利新闻

新闻公告

您的位置：网站名称 → 研发专利新闻 → 正文